| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |